Loading...

Home
ETF
CALC

CALC

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

CALC News

CalciMedica Reports FY GAAP EPS of -$1.97

Mar 03 2026seekingalpha

Wall Street Analysts Adjust Ratings

Jan 29 2026Benzinga

CalciMedica Discontinues Trial, Stock Faces Volatility

Jan 28 2026stocktwits

CalciMedica Halts KOURAGE Clinical Trial Amid Safety Concerns

Jan 28 2026Benzinga

U.S. Stocks Mixed as Energy Shares Rise Amid Crude Inventory Decline

Jan 28 2026Benzinga

U.S. Stocks Mostly Higher; Starbucks Beats Q1 Sales Expectations

Jan 28 2026Benzinga

CalciMedica Halts Auxora Clinical Trial Due to Safety Concerns

Jan 28 2026PRnewswire

CalciMedica (CALC) Anticipates Key Phase 2 Data Readout in 2026 with $14.1M Cash Position

Jan 21 2026NASDAQ.COM

CalciMedica Reports Third Quarter 2025 Financial Results and Provides Clinical & Corporate Updates

Nov 12 2025PRnewswire

CalciMedica Announces Publication in JCI Insight of Preclinical Data Supporting CRAC Channel Inhibitor as a Potential Therapy for Pulmonary Arterial Hypertension

Nov 12 2025PRnewswire

CalciMedica Presents Data from Preclinical Study of Auxora™ in an Animal Model of AKI at ASN Kidney Week 2025

Nov 10 2025PRnewswire

CalciMedica to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Sep 02 2025PRnewswire

CalciMedica Reports Second Quarter 2025 Financial Results and Provides Clinical & Corporate Updates

Aug 12 2025PRnewswire

CalciMedica to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference

Jul 08 2025Newsfilter

CalciMedica Announces Publication in the American Journal of Nephrology Discussing Design and Rationale of Phase 2 KOURAGE Trial of Auxora™ in AKI with Respiratory Failure

Jun 25 2025Newsfilter

CalciMedica Announces Upcoming Symposium at the 43rd Vicenza Course AKI-CRRT-EBPT and Critical Care Nephrology Meeting

Jun 12 2025Newsfilter